文献速递免疫规划

口服与注射亚单位嵌合疫苗候选对鸡坏死性肠炎的保护作用

Immunization with oral and parenteral subunit chimeric vaccine candidate confers protection against Necrotic Enteritis in chickens.
PubMed 文献 · Vaccine · 2020-10-02

研究将含NetB、α毒素和金属肽酶的嵌合蛋白NAM在烟草中表达为可食用疫苗,同时在大肠杆菌中表达纯化rNAM用于皮下注射。两种途径均激发强烈体液免疫,注射组抗体滴度更高且对肠道病变保护更强,口服组IgY持续时间更长。

要点

  • 口服植物表达与注射纯化嵌合疫苗均激发鸡抗产气荚膜梭菌体液免疫。
  • 注射rNAM抗体平均滴度约32000,高于口服约9000,保护肠道病变更强。
  • 口服疫苗第三次免疫后14天IgY应答比注射组更持久。

核心结论

  • 重组嵌合疫苗经注射和口服均可显著减轻产气荚膜梭菌攻击后的肠道病变,注射保护更强,但需进一步验证平台潜力。

研究设计与样本

  • 优化嵌合基因构建含NetB、α毒素和金属肽酶的NAM融合蛋白,在烟草表达为可食用疫苗,在大肠杆菌BL21表达纯化His标签rNAM用于皮下免疫。
  • 免疫后以强毒产气荚膜梭菌株在坏死性肠炎模型中进行攻击,评估抗体滴度和肠道病变。

主要发现

  • 可食用植物基和注射纯化rNAM免疫鸡均产生强 humoral 免疫应答。
  • 血液抗体平均滴度:可食用组约9000,注射rNAM组约32000,皮下免疫应答最显著。
  • 第三次免疫后14天,可食用疫苗的IgY应答比注射组更持久。
  • 表达rNAM的冻干叶或纯化rNAM免疫鸡在攻击后均显著减轻肠道病变严重程度,注射抗原保护大于口服。

局限性

  • 需进一步分析这些策略能否作为开发高效坏死性肠炎疫苗的潜在平台。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Following the ban on the use of in-feed antimicrobials, necrotic enteritis (NE) NE is the most important clostridial disease. Vaccination has been considered as a possible approach to prevent NE. Our previous study showed that a chimeric protein product consisting of antigenic epitopes of NetB, Alpha-toxin and Zinc metallopeptidase (Zmp) triggered immune response against C. perfringens. In the current study we optimized the chimeric gene and constructed a fusion protein containing NetB, Alpha-toxin and Metallopeptidase (NAM) for expressing in tobacco plant to use as an edible vaccine for immunizing the chicken against NE. Simultaneously, we expressed and purified a His-tagged recombinant version of the NAM (rNAM) expressed in E. coli BL21 for subcutaneous immunization of chickens. Immunized birds produced strong humoral immune responses against both edible plant-based and parenteral purified rNAM. The responses were determined by the mean titer of antibody in blood samples to be around 9000 and 32,000, for edible and injected rNAM, respectively. Birds immunized subcutaneously showed the most striking responses. However the edible vaccine provided a more long lasting IgY response 14 days after the third vaccination compared to the injected birds. Chickens immunized with either lyophilized leaves expressing rNAM or purified rNAM, subsequently were subjected to the challenge with a virulent C. perfringens strain using an NE disease model. Our results showed that birds immunized both parenterally and orally with recombinant chimeric vaccine were significantly protected against the severity of lesion in the intestinal tract, but the protection provided with the injectable form of the antigen was greater than that of the oral form. Further analysis is needed to check whether these strategies can be used as the potential platform for developing an efficient vaccine against NE.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Katalani C, Ahmadian G, Nematzadeh G, et al. Immunization with oral and parenteral subunit chimeric vaccine candidate confers protection against Necrotic Enteritis in chickens. Vaccine. 2020. PMID: 33012608. doi:10.1016/j.vaccine.2020.09.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。